keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day Three - CT (Central Time)
Sort by time keyboard_arrow_down
- Sort by time
- Sort by stream
Grid Viewview_column
keyboard_arrow_leftSearch & Filter
search
Free / Premium
Streams
Formats
Day Three - CT (Central Time)
search
Free / Premium
Streams
Formats
7:45am - 8:45am60 mins
General Session
Networking Breakfast in the Exhibit Hall
8:45am - 9:00am15 minsFree
General Session
Co-Chairperson's Opening Remarks
- J'Aime Conrod, MSPH - Vice President, Government Business & Healthcare Policy, Amneal Pharmaceuticals
9:00am - 10:10am70 minsFree
General Session
Fireside Chat: External Counsel Roundtable
- Tom Evegan - Principal, Strategy & Management Consulting, RSM US LLP
- Jeffrey Handwerker - Partner, Arnold & Porter LLP
- Margaux Hall - Partner, Ropes & Gray LLP
- Alice Valder Curran - Partner, Global Regulatory, Hogan Lovells
- John Shakow - Partner, King & Spalding
- Rujul Desai - Partner, Covington & Burling LLP
10:10am - 10:50am40 mins
General Session
Morning Networking Break
10:50am - 11:30am40 minsFree
Track D: Hot Topic Review
Navigating the Complexities of GP Recalculations across Government Programs
- Chris Cobourn - Managing Director GP Practice Lead, Helio
- William Sarraille - Regulatory Consultant, Sarraille & Associates
- Joe Skupen - GP Advisory Technical Lead, Helio GP Advisory Services
- Marijo Bustos - Head of Government Pricing & Reimbursements, UCB, Inc.
10:50am - 11:30am40 mins
Track E: State-Level Trends and Regulatory Movement
Exploring Risks and Enforcement Trends for Buy-and-Bill Drugs
- Margaux Hall - Partner, Ropes & Gray LLP
- Alison Fethke - Counsel, Ropes & Gray LLP
- Eve Brunts - Partner, Ropes & Gray
10:50am - 11:30am40 mins
Track F
HRSA 340B Program Manufacturer Audit Process
- Lauren D’Onofrio, MBA - Program Analyst, Office of Pharmacy Affairs, Office of Special Health Initiatives, Health Resources & Services Administration (HRSA)
- Julie Zadecky, PharmD, BCNP - Pharmacist, Office of Pharmacy Affairs, Office of Special Health Initiatives, Health Resources & Services Administration (HRSA)
11:30am - 12:10pm40 minsFree
Track D: Hot Topic Review
Smoothing Program: New Discount on Drug Program Explained
- Mallory O’Connor - Executive Director, Public Policy, Mallinckrodt Pharmaceuticals
- Chris Callahan - Associate Director, Riparian
11:30am - 12:10pm40 mins
Track E: State-Level Trends and Regulatory Movement
PDAB and SPTR Best Practices
- Pari Mody - Senior Associate, Arnold & Porter, Arnold & Porter
11:40am - 12:50pm70 mins
Track F
Closed Door Executive Strategy Summit
- J'Aime Conrod, MSPH - Vice President, Government Business & Healthcare Policy, Amneal Pharmaceuticals
- Katheryne Richardson, PharmD - Vice President, Global Pricing and Health Systems Analytics, Bristol Myers Squibb
- Rosalind Davis - Director, Government Pricing and Contracts, CSL Vifor
12:10pm - 1:00pm50 minsFree
Track D: Hot Topic Review
Networking Lunch in the Exhibit Hall
12:10pm - 1:00pm50 mins
Track E: State-Level Trends and Regulatory Movement
Networking Lunch in the Exhibit Hall
1:00pm - 1:40pm40 mins
General Session
Recent OIG Evaluations Involving Prescription Drug Pricing, Payment, and Coverage – LIVE STREAM
- David Tawes - Regional Inspector General, Department of Health and Human Services, Office of Inspector General
- Michael Kvassay - Team Leader, Department of Health and Human Services, HHS Office of Inspector General
1:40pm - 2:20pm40 minsFree
General Session
Medicaid Expansion Challenges
- Sabrina Aery - Executive Director, US Government Programs, Bristol-Myers Squibb
- James Kelly - Director, Medicaid, Novartis Pharmaceuticals Corporation
2:20pm - 2:25pm5 mins
Close of Conference - See You in 2025!
Filter
Free / Premium
Streams
Formats
Choose Day